Special Ad-Hoc Call "Repurposing Drugs for EB" 2022

  • Descripción: EB Resnet has agreed to provide an additional funding stream to support proof-of-concept projects aimed at exploring possible repurposing opportunities that tackle the following EB’s unmet medical needs:
    •     Chronic inflammation and fibrosis
    •     Pain
    •     Itch
    •     Cutaneous squamous cell carcinoma (cSCC)
  • Linkhttps://www.eb-researchnetwork.org/funding-opportunities/ad-hoc-funding-round-2022/

Entidad Financiadora: EB Research Funding

Plazo de Presentación: 06/09/2022

Volver al Listado